Related Experiment Video
Updated: Jun 26, 2026
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Rupture and intra-peritoneal bleeding of a hepatocellular carcinoma after a transarterial chemoembolization
Artan Reso1, Chad G Ball, Francis R Sutherland
1University of Calgary, Department of Surgery, Foothills Hospital, 1403-29 St N,W, T2N 2T9, Calgary, Alberta, Canada. ball.chad@gmail.com.
Background:
Transarterial chemoembolization (TACE) is a well accepted treatment for inoperable hepatocellular carcinoma (HCC). While minor complications involve 10% of all patients, severe complications are rare.
Case Presentation:
We describe a case of a 90-year-old male with a large, superficial HCC who underwent TACE. He had a significant intraperitoneal bleed secondary to tumor rupture immediately following the procedure.
Conclusion:
Tumor size and superficial location must be considered risk factors for tumor rupture and related complications.
